Novavax among 9 biopharmas to make 'scientific process' pledge amid rush for Covid-19 vaccine development

The pledge comes amid mounting pressure from the Trump administration to deliver a coronavirus vaccine in early November.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.